Investigator

Rama Jayaraj

Professor · O. P. Jindal Global University, Department of Clinical Sciences

RJRama Jayaraj
Papers(2)
Comments on “Cumulati…A Clinical Investigat…
Collaborators(8)
Ravishankar Ram ManiSasikala ChinnappanSunil KrishnanGothandam Kodiveri Mu…Madanmohan GuptaMogana RajagopalPeter ShawRaghul Senthilnathan
Institutions(5)
Nanjing University Of…Ucsi UniversityMayo Clinic In FloridaVellore Institute Of …University Of The Wes…

Papers

A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis

Background: The most often diagnosed malignancy in women worldwide is cancer of the cervix. It is also the most prevalent kind of gynecological cancer in women. This cancer originates in the opening of the cervix and spreads through sexual contact. Even though human papillomavirus (HPV) may not cause cancer immediately, it does develop over time as a result of the virus’s lengthy persistence to cause dysplastic changes overtime, particularly in high-risk kinds. The primary objective of this research is to see if miRNAs are dysregulated as a result of treatment resistance in cervical cancer (CC). The aim is to see if these microRNAs may be utilized as biomarkers for detecting chemoresistance in CC, particularly for clinical applications. Methods: The recommended protocol for comprehensive study and meta-analysis (PRISMA-P) standards will be utilized for the analysis and data interpretation. The bibliographic databases will be methodically searched using a combination of search keywords. Based on established inclusion and exclusion criteria, the acquired findings will be reviewed, and data retrieved from the selected scientific papers for systematic review. We will then construct a forest from the pooled Hazard ratio (HR) and 95% C.I. values, data obtained using the random-effects model. Discussion: The focus of this study is to identify the function of miRNAs as a chemoresistance regulator and determine if they have the potential scope to be considered as biomarkers for cervical cancer. Through this systematic review and meta-analysis, the goal is to collect, compare, and analyze the data pertaining to the role of miRNAs in cervical cancer, thereby, enabling us to understand the role they play in chemosensitivity.

173Works
2Papers
8Collaborators
Biomarkers, TumorPrognosisHead and Neck NeoplasmsDrug Resistance, NeoplasmBreast NeoplasmsUterine Cervical NeoplasmsColorectal NeoplasmsNeoplasms

Positions

Professor

O. P. Jindal Global University · Department of Clinical Sciences

2010–

Senior Lecturer - Clinical Sciences

Charles Darwin University · School of Psychological and Clinical Sciences

2008–

Senior Research Officer

Menzies School of Health Research · Infectious Diseases and Mental Health and Wellbeing

Education

2017

Master of Public Health (MPH)

Charles Darwin University · Clinical Sciences

2012

Graduate Certificate of Teaching and Learning - Higher Education

Charles Darwin University · School of Education

2008

Doctorate of Philosphy

Royal Melbourne Institute of Technology · School of Biotechnology

2003

Master of Veterinary Science

Madras Veterinary College · Department of Animal Genetics and Breeding

2001

Bachelor of Veterinary Sciences

Madras Veterinary College

Country

AU

Keywords
Molecular OncologyMeta-AnalysisOral Cancer